Streetbeat News

Earnings

CPRX

Catalyst Pharmaceuticals (NASDAQ:CPRX) reported Q4 adjusted EPS of $0.53, surpassing the $0.26 estimate, and sales of $110.57M, exceeding the $106.12M estimate. This represents a significant increase in both earnings and sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 7:29 am

VIA

Via Renewables reported a Q4 EPS of $(0.93), a 9.41% decrease from $(0.85) YoY, with sales of $101.70M, down 13.36% from $117.38M YoY.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 7:27 am

FWRD

Forward Air (NASDAQ:FWRD) reported Q4 adjusted EPS of $0.81, missing the $0.98 estimate, and sales of $338.43M, missing the $407.76M estimate. This represents a significant decrease from the same period last year, with earnings down 50.91% and sales down 29.67%.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 7:24 am

NBBK

NB Bancorp reported its FY23 financial results, showcasing an adjusted EPS of $0.82 and a revenue increase to $145.63M from $114.24M YoY. Total assets reached $4.53 billion as of December 31, 2023, marking a 26.2% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 7:19 am

CRH

CRH reported a strong FY23 performance with a 7% increase in revenue to $34.9B and a 30% increase in adjusted EPS to $4.65. The company benefited from good demand, positive pricing, and acquisitions, leading to a 14% increase in income from continuing operations to $3.1B and a 15% increase in Adjusted EBITDA to $6.2B. Margins also improved, with income from continuing operations margin at 8.8% and Adjusted EBITDA margin at 17.7%.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 7:16 am

TALO

Talos Energy projects its 2024 production to range between 87,000 and 93,000 barrels of oil equivalent per day, with over 70% being oil. This forecast includes contributions from QuarterNorth for only nine months. The company anticipates reducing its upstream capital expenditures to between $565 million and $595 million, down from its 2023 levels. Talos is also exploring strategic options for its Talos Low Carbon Solutions subsidiary and aims to significantly reduce its debt while investing in key upstream projects. With recent pricing, Talos targets a year-end 2024 leverage of 1.0x or less, planning to pay down approximately $400 million in debt through cash flow, not including any proceeds from TLCS.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 7:10 am

TALO

Talos Energy (TALO) reported a Q4 adjusted EPS of $(0.01), missing the $0.17 estimate, and sales of $384.96M, missing the $389.57M estimate. This represents a 105% decrease in EPS from last year's $0.20, despite a 12.49% increase in sales from $342.20M.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 7:05 am

VRNA

Verona Pharma reported a Q4 EPS of $(0.02), unchanged from the previous year, with a cash balance of $271.8M.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 7:04 am

ARGX

argenx (NASDAQ:ARGX) reported Q4 earnings with losses of $(1.68) per share, surpassing the $(1.71) estimate. Sales reached $417.84M, exceeding the $364.75M forecast, marking a significant increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 6:56 am

BUD

Anheuser-Busch reported a decline in total volumes by 2.6%, with its own beer volumes decreasing by 3.6%. However, non-beer volumes saw an increase of 3%.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 6:53 am